We are excited to report that our latest discoveries on a novel treatment of hypertension were published in the AHA journal Hypertension, and the article was selected to be a “High Impact Paper in Hypertension”! Our study identifies a novel role of E2F1/2/3a-dependent mechanism in the reduction of blood pressure.